The BK virus in renal transplant recipients—review of pathogenesis, diagnosis, and treatment
✍ Scribed by Vikas R. Dharnidharka; Husam A. Abdulnour; Carlos E. Araya
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 336 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract BK virus associated nephropathy occurs in approximately 5% of renal transplant recipients. Quantitation of BKV DNA in serum/plasma early in the course of disease has been suggested to be an important diagnostic tool for polymavirus‐associated nephropathy (PVAN). The aim of this study wa
## Abstract Polyomavirus BK (BKV) is a common human polyomavirus that rarely causes clinical symptoms in immunocompetent individuals. However, BK virus reactivation occurs in 20–40% of kidney transplant patients and 1–10% of cases present with BK virus‐associated nephropathy (BKVN) and reduced kidn
BK polyomavirus (BKV) is a ubiquitous virus in humans that remains latent in the urogenital tract after a primary infection during childhood. The virus, which is reactivated frequently and excreted in urine, can cause nephropathy in renal transplant recipients. BKV sequences are classified into four
## Abstract Polyomavirus‐associated nephropathy (PVAN) is a major complication that occurs after renal transplantation and is induced by reactivation of the human polyomavirus BK (BKV). The structure of the viral capsid protein 1 (VP1) is characterized by the presence of external loops, BC, DE, EF,
The following sentences from the article abstract are corrected as follows: BKVN was confirmed histologically in 3/120 patients and viremic patients were treated with dialysis for longer time periods and had higher levels of panel reactive antibodies. In conclusion, polyoma BK viremia and viruria